BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35136950)

  • 1. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
    Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
    Fung MHM; Lang BHH
    Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
    Ma EZ; Kuo JH; Malek R; Turner DJ; Olson JA; Slejko JF; Mullins CD; Hu Y
    Surgery; 2023 Jan; 173(1):193-200. PubMed ID: 36208983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Health by Graves' Disease Management Modality - Surgery Versus Radioactive Iodine Versus Antithyroid Medications: A Network Meta-Analysis.
    Issa PP; Hussein M; Omar M; Munshi R; Attia AS; Buti Y; Aboueisha M; Shama M; Toraih E; Kandil E
    J Surg Res; 2023 Mar; 283():266-273. PubMed ID: 36423475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
    Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, management and outcomes of Graves' disease-real life data.
    Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
    Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature.
    El Kawkgi OM; Ross DS; Stan MN
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):3-12. PubMed ID: 33283314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
    Hegedüs L
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
    Wartofsky L
    Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimal treatment for pediatric Graves' disease is radioiodine.
    Rivkees SA; Dinauer C
    J Clin Endocrinol Metab; 2007 Mar; 92(3):797-800. PubMed ID: 17341574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
    Thakur PS; Kumar C
    Surgery; 2023 May; 173(5):1311. PubMed ID: 36528405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role and effectiveness of radioactive-iodine therapy for the treatment of Grave's disease].
    Sellem A; Elajmi W; Mhamed RB; Oueslati N; Ouertani H; Hammami H
    Pan Afr Med J; 2020; 36():341. PubMed ID: 33193994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.